Biogen’s Leqembi to drive Alzheimer’s market to $14B in 2030
filadendron/E+ by way of Getty Photographs Pushed by novel therapeutics from Biogen (NASDAQ:BIIB)/ Eisai (OTCPK:ESALF) and ...
Read more
Tag: 14B
Premium Content
Copyright © 2022 Real Invest Solutions.